Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer

Korkmaz E. T., KÖKSAL D., Aksu F., DİKMEN Z. G., İÇEN D., Maden E., ...More

CLINICAL BIOCHEMISTRY, vol.58, pp.15-19, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 58
  • Publication Date: 2018
  • Doi Number: 10.1016/j.clinbiochem.2018.05.001
  • Journal Name: CLINICAL BIOCHEMISTRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.15-19
  • Hacettepe University Affiliated: Yes

Abstract

Background and aim: Early diagnosis and histological subtyping are important issues in the management of patients with lung cancer (LC). The aim of this study is to investigate the diagnostic value of a panel of serum tumor markers in newly diagnosed patients with LC.